Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 11
Submit an article Journal homepage
195
Views
1
CrossRef citations to date
0
Altmetric
Articles Commentary

Should high risk smoldering myeloma be treated outside a clinical trial: NO

Morie A Gertza Division of Hematology, Mayo Clinic, Rochester, MN, USACorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0002-3853-5196
ORCID Icon &
Iuliana Vaxmana Division of Hematology, Mayo Clinic, Rochester, MN, USA;b Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center Petah- Tikvah, Petah Tikva, Israel;c Sackler Faculty of Medicine Tel-Aviv University, Tel-Aviv, Israel
Pages 2565-2567 | Received 11 Jun 2021, Accepted 26 Jun 2021, Published online: 14 Jul 2021

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.